The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca (Inst); Clovis Oncology (Inst); MSD Oncology (Inst)
Research Funding - PharmaMar (Inst)
Expert Testimony - Clovis Oncology (Inst); Onxeo (Inst); Roche
Travel, Accommodations, Expenses - AstraZeneca; Roche; Tesaro
Optimal treatment duration of bevacizumab (BEV) combined with carboplatin and paclitaxel in patients (pts) with primary epithelial ovarian (EOC), fallopian tube (FTC) or peritoneal cancer (PPC): A multicenter open-label randomized 2-arm phase 3 ENGOT/GCIG trial of the AGO Study Group, GINECO, and NSGO (AGO-OVAR 17/BOOST, GINECO OV118, ENGOT Ov-15, NCT01462890).
 
Jacobus Pfisterer
Honoraria - Amgen; AstraZeneca; Axiom Healthcare Strategies; Bionest Partner; Chugai Pharma; Clovis Oncology; Decision Resources; GlaxoSmithKline; iMed Institut; Juniper Pharmaceuticals; Medupdate; MSD Oncology; Prosapient; Roche Pharma AG; SAI MedPartners; Simon-Kucher and Partners; Tesaro; Teva; Vox.Bio
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; MSD Oncology; Roche Pharma AG; Tesaro
Research Funding - Roche Pharma AG (Inst); Roche Pharma AG (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Roche Pharma AG
 
Florence Joly
Honoraria - Amgen; Astellas Pharma; AstraZeneca; GlaxoSmithKline; Ipsen; Roche; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; GlaxoSmithKline; Ipsen; Janssen; MSD Oncology; Pfizer; Sanofi
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Ipsen; Janssen; Roche
 
Gunnar Kristensen
No Relationships to Disclose
 
Joern Rau
No Relationships to Disclose
 
Sven Mahner
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Janssen-Cilag; Jenapharm; Medac; Novartis/Pfizer; PharmaMar; Roche/Genentech; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Immunogen; Janssen-Cilag; Medac; Merck Sharp & Dohme; Roche; Sensor-Kinesis Corp.; Tesaro
Research Funding - AstraZeneca; Bayer; Boehringer Ingelheim; GlaxoSmithKline; Janssen-Cilag; Medac; PharmaMar; Roche; Tesaro
 
Patricia Pautier
No Relationships to Disclose
 
Ahmed El-Balat
Honoraria - AstraZeneca; Clovis Oncology; Olympus Medical Systems; Roche Pharma AG
Consulting or Advisory Role - GlaxoSmithKline; MSD; Myriad Genetics; PharmaMar; Roche Pharma AG
Travel, Accommodations, Expenses - AstraZeneca; Olympus Medical Systems; PharmaMar
 
Jean Emmanuel Kurtz
Honoraria - Clovis Oncology; GlaxoSmithKline
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; TESARO
Travel, Accommodations, Expenses - PharmaMar; Roche; TESARO
 
Ulrich Canzler
Speakers' Bureau - Lilly
 
Jalid Sehouli
Honoraria - AstraZeneca; Bayer; Clovis Oncology; Eisai; GlaxoSmithKline; Johnson & Johnson; MSD Oncology; Olympus Medical Systems; Pfizer; PharmaMar; Tesaro; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Ingress Health; Johnson & Johnson; Lilly; Merck; MSD Oncology; Novartis; Novocure; Pfizer; PharmaMar; Riemser; Roche; Sobi; Tesaro
Research Funding - AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD Oncology; Olympus; PharmaMar; Roche Pharma AG; Tesaro; Tesaro
 
Martin L. Heubner
Honoraria - Intuitive Surgical; Olympus
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Roche
Travel, Accommodations, Expenses - GlaxoSmithKline; Roche
 
Andreas D. Hartkopf
Honoraria - Agendia; Amgen; AstraZeneca; Daiichi Sankyo; Genomic Health; GlaxoSmithKline; Lilly; MSD; Novartis; Pfizer; Roche; Seagen
 
Klaus Baumann
No Relationships to Disclose
 
Annette Hasenburg
Honoraria - AstraZeneca; LEO Pharma; Med Update; MedConcept; Pfizer; Roche; Streamedup!; Tesaro
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline/MSD; LEO Pharma; PharmaMar; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; MedConcept; MedUpdate; Pfizer; Roche; Streamedup!; Tesaro
 
Lars Ch. Hanker
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; GlaxoSmithKline; Novartis; Roche Pharma AG; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Intuitive Surgical; PharmaMar; Roche Pharma AG; Tesaro
 
Antje Belau
No Relationships to Disclose
 
Barbara Schmalfeldt
Honoraria - AstraZeneca; Clovis Oncology; Ethicon; GlaxoSmithKline; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; Roche; Tesaro
Research Funding - AstraZeneca (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Ethicon; PharmaMar
 
Dominik Denschlag
Honoraria - AstraZeneca; Clovis Oncology; KLS Martin; MSD; PharmaMar; Roche; Tesaro/GSK
Consulting or Advisory Role - AstraZeneca; PharmaMar; Roche; Tesaro/GSK
 
Tjoung-Won Park-Simon
Honoraria - AstraZeneca; Daiichi Sankyo Europe GmbH; Genomic Health International; GlaxoSmithKline; Lilly; MSD; Novartis; Pfizer; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Hexal; Lilly; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Pfizer; Roche; Tesaro
 
Philipp Harter
Honoraria - AstraZeneca; Clovis Oncology; Lilly; MSD Oncology; Roche; Sotio; Stryker; Tesaro; Zai Lab
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Immunogen; Merck; Roche; Tesaro
Research Funding - AstraZeneca (Inst); Genmab (Inst); Roche (Inst); Tesaro (Inst)